0001209191-20-059255.txt : 20201118
0001209191-20-059255.hdr.sgml : 20201118
20201118193043
ACCESSION NUMBER: 0001209191-20-059255
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201116
FILED AS OF DATE: 20201118
DATE AS OF CHANGE: 20201118
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Renaud Ronald C JR
CENTRAL INDEX KEY: 0001354434
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38550
FILM NUMBER: 201326657
MAIL ADDRESS:
STREET 1: C/O IDENIX PHARMACEUTICALS, INC.
STREET 2: 60 HAMPSHIRE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Translate Bio, Inc.
CENTRAL INDEX KEY: 0001693415
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 611807780
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 29 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 617-945-7361
MAIL ADDRESS:
STREET 1: 29 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: RaNA Therapeutics, Inc.
DATE OF NAME CHANGE: 20161228
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-11-16
0
0001693415
Translate Bio, Inc.
TBIO
0001354434
Renaud Ronald C JR
C/O TRANSLATE BIO, INC.
29 HARTWELL AVE
LEXINGTON
MA
02421
1
1
0
0
Chief Executive Officer, Pres.
Common Stock
2020-11-16
4
M
0
53004
7.39
A
488563
D
Common Stock
2020-11-16
4
M
0
3
8.34
A
488566
D
Common Stock
409913
I
By Ronald Renaud 2014 Irrevocable Family Trust
Common Stock
40909
I
By Ronald C. Renaud, Jr. Trust - 2007
Stock Option (right to buy)
7.39
2020-11-16
4
M
0
53004
0.00
D
2027-12-21
Common Stock
53004
1085673
D
Stock Option (right to buy)
8.34
2020-11-16
4
M
0
3
0.00
D
2028-03-06
Common Stock
3
89997
D
This option was granted on December 22, 2017. The shares underlying the option are scheduled to vest over four years in equal monthly installments through March 9, 2021.
This option was granted on March 7, 2018. 25% of the shares vested on March 7, 2019 and the remainder are scheduled to vest in equal monthly installment through March 7, 2022.
/s/ Paul Burgess, as attorney-in-fact for Ronald C. Renaud, Jr.
2020-11-17